Page last updated: 2024-09-05

vx-745 and Kahler Disease

vx-745 has been researched along with Kahler Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akiyama, M; Anderson, KC; Chauhan, D; Hayashi, T; Hideshima, T; Richardson, P; Schlossman, R	1

Other Studies

1 other study(ies) available for vx-745 and Kahler Disease

Article	Year
Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu. Blood, 2003, Jan-15, Volume: 101, Issue:2 Topics: Bone Marrow Cells; Cell Adhesion; Cell Division; Endothelial Growth Factors; Enzyme Inhibitors; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-6; Lymphokines; Mitogen-Activated Protein Kinases; Multiple Myeloma; p38 Mitogen-Activated Protein Kinases; Paracrine Communication; Pyridazines; Pyrimidines; Stromal Cells; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2003

Article

Year

Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu.

Blood, 2003, Jan-15, Volume: 101, Issue:2

Topics: Bone Marrow Cells; Cell Adhesion; Cell Division; Endothelial Growth Factors; Enzyme Inhibitors; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-6; Lymphokines; Mitogen-Activated Protein Kinases; Multiple Myeloma; p38 Mitogen-Activated Protein Kinases; Paracrine Communication; Pyridazines; Pyrimidines; Stromal Cells; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2003